Fig. 1From: Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s diseaseOverview of the experimental protocol. The upper section illustrates the temporal experimental setup with the experimental foci. Systemic intraperitoneal injection of MCC950 started 24 h after AAV1/2 viral vector injection in the right substantia nigra. The lower section illustrates the experimental grouping. Created with BioRender.comBack to article page